Inventor
JOHN G. FLANNERY
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
C12NMicroorganisms or enzymes24%
A61KPreparations for medical, dental or toiletry purposes20%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
PatentTitleYear
12,310,997Compositions and methods of treating ocular diseases202512,031,147Adeno-associated virus virions with variant capsids and methods of use thereof202411,565,001Adeno-associated virus virions with variant capsid and methods of use thereof202311,565,000Adeno-associated virus virions with variant capsid and methods of use thereof202311,554,180Adeno-associated virus virions with variant capsid and methods of use thereof202311,236,402Adeno-associated virus virions with variant capsid2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to UNIV CALIFORNIA (6)· patent assignee history
2022–2025Based in US· patent location history
2023Patents assigned to UNIV PENNSYLVANIA (3)· patent assignee history
2024Patents assigned to NOVARTIS AG (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV CALIFORNIA | 6 | 2022–2025 |
| UNIV PENNSYLVANIA | 3 | 2023 |
| NOVARTIS AG | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |